Plenary Sessions-18/04/2020

Saturday, April 18th, 2020

8:30 – 10:45

Plenary session 3: Hematological malignancies

Chairs: H Ten Cate (The Netherlands), F Rodeghiero (Italy)

PL10 - Risk-assessment of thrombosis and bleeding in hematological malignancies
B Brenner (Israel)

PL11 - Advances in management of coagulopathy in APL
MA Sanz (Spain)

PL12 - Anticoagulant and antiplatelet treatment in cancer patients with thrombocytopenia
A Leader (Israel)

PL13 - Multiple myeloma-associated VTE risk prediction
K Sanfilippo (USA)

Selected Abstract

10:45 - 11:15

Coffee Break

11:15 – 12:15

Plenary Lecture: 6th Simon Karpatkin Memorial Lecture

Chairs: Anna Falanga (Italy); Benjamin Brenner (Israel); Alok A Khorana (USA)

Introduction to Lecture
FR Rickles (USA)

Risk prediction for cancer-associated thrombosis in ambulatory patients with cancer - past, present and future
I Pabinger (Austria)

12:15 – 13:15

Roundtable: Emerging practical guidelines for the prevention and treatment of CAT

Chairs: K Syrigos (Greece), R Labianca (Italy)

Introduction: Overview of VTE treatment and prevention in cancer according to clinical guidelines
G Lyman (USA)

Discussant: G Lyman (USA), I Elalamy (France), A Falanga (Italy), D Farge-1bancel (France), K Jordan (Germany), A Lee (Canada)

13:15 - 14:15

Lunch Sessions

14:15 - 16:15

Poster Sessions with coffee and pastries

16:15 – 18:00

Plenary Session 4: Prevention of VTE in cancer patients

Chairs: Paolo Prandoni (Italy), JA Paramo (Spain)

PL14 - Inpatient thromboprophylaxis in cancer patients: what is the evidence?
J Zwicker (USA)

PL15 - Roles of LMWH for prevention in cancer patients
A Maraveyas (UK)

PL16 - Meta-analysis and systematic review of NOAC prophylaxis in high risk cancer outpatients
N Kuderer (USA) 

Selected Abstract 

18:00 – 19:00

Debate: Outpatient prophylaxis: are we there yet?

Chairs: G Agnelli (Italy), C Francis (USA)

NO: H Buller (The Netherlands)

YES: AA Khorana (USA)